News Stories

[TnHepGuy_]

<a href="http://www.hcvadvocate.org/news/newsRev/2005/NewsRev-88.html#10">Bioenvision Evaluates New Agent in Fight against Hepatitis C; Patient Enrollment Begins in Multi-Center, International Phase II Clinical Trial</a>

<a href="http://www.hcvadvocate.org/news/newsRev/2005/NewsRev-88.html#11">Human Genome Sciences Completes Enrollment in a Phase 2 Clinical Trial of Albuferon(TM) in Treatment-Naive Patients with Chronic Hepatitis C</a>

<a href="http://www.natap.org/2005/HCV/022205_05.htm">How Hepatitis C Short-Circuits the Immune System</a>

<a href="http://www.natap.org/2005/HCV/022205_03.htm">Medicaid Utilization of IFN/RBV for HCV Therapy</a>

<a href="http://www.natap.org/2005/HCV/022205_02.htm">
CD8/CTLs Predict Response to IFN/RBV Therapy</a>

<a href="http://www.natap.org/2005/HCV/021805_01.htm">The Spectrum of Chronic Hepatitis C Virus Infection in the Virginia Correctional System: Development of a Strategy for the Evaluation and Treatment of Inmates with HCV</a>

<a href="http://www.hivandhepatitis.com/hep_c/news/2005/021805_a.html">Predicting Progressive Hepatic Fibrosis Stage on Subsequent Liver Biopsy</a>

<a href="http://www.hivandhepatitis.com/hep_c/news/2005/021805_b.html">Persistence of HCV After Successful Treatment of Chronic Hepatitis C: Is HCV Infection for Life?</a>

<a href="http://www3.interscience.wiley.com/cgi-bin/abstract/109930117/ABSTRACT">Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma</a>

[TnHepGuy_]

<a href="http://www3.interscience.wiley.com/cgi-bin/abstract/109930115/ABSTRACT">Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C</a>

<a href="http://www3.interscience.wiley.com/cgi-bin/abstract/109930098/ABSTRACT">SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma</a>

<a href="http://www3.interscience.wiley.com/cgi-bin/abstract/109930100/ABSTRACT">Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection</a>

<a href="http://www3.interscience.wiley.com/cgi-bin/abstract/109930101/ABSTRACT">Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis</a>

<a href="http://www.blackwell-synergy.com/links/doi/10.1111/j.1478-3231.2005.01028.x/abs/">Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy</a>

<a href="http://www.blackwell-synergy.com/links/doi/10.1111/j.1478-3231.2005.1040.x/abs/">Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon -2b and ribavirin</a>